Ningbo Menovo Pharm Co Ltd (603538) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Ningbo Menovo Pharm Co Ltd (603538) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥38.86 Million ≈ $5.69 Million USD) by net assets (CN¥2.42 Billion ≈ $353.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603538 equity to assets ratio to measure how much of total assets are equity-financed.

Ningbo Menovo Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Ningbo Menovo Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ningbo Menovo Pharm Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Ningbo Menovo Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ningbo Menovo Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sats ASA OL:SATS	0.451x
BCI Minerals Ltd AU:BCI	0.024x
Janux Therapeutics Inc NASDAQ:JANX	-0.013x
Zhejiang Goldensea Envi Tech C SHG:603311	0.021x
Bafang Electric Suzhou Co Ltd SHG:603489	0.017x
Create Technology & Science Co Ltd SHE:000551	0.010x
Wanbangde Pharmaceutical Holding Group Co Ltd SHE:002082	0.000x
Center Laboratories TWO:4123	0.002x

Annual Cash Flow Conversion Efficiency for Ningbo Menovo Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Ningbo Menovo Pharm Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Ningbo Menovo Pharm Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.45 Billion ≈ $358.64 Million	CN¥157.56 Million ≈ $23.06 Million	0.064x	+51.03%
2024-12-31	CN¥2.29 Billion ≈ $335.31 Million	CN¥97.54 Million ≈ $14.27 Million	0.043x	+918.66%
2023-12-31	CN¥2.19 Billion ≈ $319.83 Million	CN¥9.13 Million ≈ $1.34 Million	0.004x	-96.72%
2022-12-31	CN¥2.17 Billion ≈ $318.01 Million	CN¥276.95 Million ≈ $40.53 Million	0.127x	+14.28%
2021-12-31	CN¥1.98 Billion ≈ $289.52 Million	CN¥220.63 Million ≈ $32.28 Million	0.112x	-21.89%
2020-12-31	CN¥1.76 Billion ≈ $257.91 Million	CN¥251.61 Million ≈ $36.82 Million	0.143x	+24.57%
2019-12-31	CN¥1.57 Billion ≈ $229.52 Million	CN¥179.75 Million ≈ $26.30 Million	0.115x	+229.61%
2018-12-31	CN¥1.34 Billion ≈ $196.11 Million	CN¥46.60 Million ≈ $6.82 Million	0.035x	-49.57%
2017-12-31	CN¥1.16 Billion ≈ $170.11 Million	CN¥80.15 Million ≈ $11.73 Million	0.069x	-57.01%
2016-12-31	CN¥731.02 Million ≈ $106.97 Million	CN¥117.24 Million ≈ $17.16 Million	0.160x	-22.37%
2015-12-31	CN¥645.81 Million ≈ $94.50 Million	CN¥133.42 Million ≈ $19.52 Million	0.207x	+55.00%
2014-12-31	CN¥564.34 Million ≈ $82.58 Million	CN¥75.22 Million ≈ $11.01 Million	0.133x	-56.46%
2013-12-31	CN¥487.44 Million ≈ $71.33 Million	CN¥149.21 Million ≈ $21.83 Million	0.306x	+255.52%
2012-12-31	CN¥442.58 Million ≈ $64.76 Million	CN¥38.11 Million ≈ $5.58 Million	0.086x	-73.22%
2011-12-31	CN¥378.47 Million ≈ $55.38 Million	CN¥121.67 Million ≈ $17.80 Million	0.321x	--

About Ningbo Menovo Pharm Co Ltd

SHG:603538 China Drug Manufacturers - Specialty & Generic

Market Cap

$878.30 Million

CN¥6.00 Billion CNY

Market Cap Rank

#9307 Global

#2293 in China

Share Price

CN¥24.72

Change (1 day)

+3.04%

52-Week Range

CN¥19.24 - CN¥68.50

All Time High

CN¥68.50